PPY A |
| Catalog No.GC12779 |
PPY A es un potente inhibidor de quinasas Abl mutante T315I y de tipo salvaje con IC50 de 9 y 20 nM, respectivamente. PPY A inhibe las células Ba⁄F3 transformadas con Abl de tipo salvaje y Abl T315I mutante con IC50 de 390 y 180 nM, respectivamente. PPY A se puede utilizar para la investigación de la leucemia mieloide crónica (LMC).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 875634-01-8
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Potent inhibitor of T315l mutant and wild-type Abl kinases (IC50 values are 9 and 20 nM, respectively). Inhibits growth of cells transformed with either the Bcr-Abl T315l mutant or wild-type Bcr-Abl gene.
Review for PPY A
Average Rating: 5 (Based on Reviews and 10 reference(s) in Google Scholar.)
Review for PPY A
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *